Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib and Letrozole in Advanced Endometrial Cancer
NCT04393285Phase 2Active, not recruiting
- Sponsor
- GOG Foundation
- Start
- Oct 2020
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in endometrial cancer (EC), sponsored by GOG Foundation. Started Oct 2020; status: active, not recruiting.
02
Drugs
abemaciclib
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT04393285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04393285.